Proposed Data Collections Submitted for Public Comment and Recommendations, 35166-35169 [2014-14339]
Download as PDF
<![CDATA[
35166
Federal Register / Vol. 79, No. 118 / Thursday, June 19, 2014 / Notices
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
FoodNet Non-O157 Shiga ToxinProducing E. coli Study: Assessment of
Risk Factors for Laboratory-Confirmed
Infections and Characterization of
Illnesses by Microbiological
Characteristics (OMB No. 0920–0905,
expires 11/30/14)—Extension—National
Center for Emerging and Zoonotic
Infectious Diseases, Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Each year many Shiga toxinproducing E. coli (STEC) infections
occur in the United States, ranging in
severity from mild diarrhea, to
hemorrhagic colitis and in some cases,
life-threatening hemolytic uremic
syndrome (HUS). HUS occurs most
frequently following infection with
serogroup O157; 6% of patients with
this type of STEC infection develop
HUS, with highest occurrence in
children aged <5 years. HUS has a
fatality rate of approximately 5%; up to
25% of HUS survivors are left with
chronic kidney damage.
STEC are broadly categorized into two
groups by their O antigens, STEC O157
and non-O157 STEC. The serogroup
O157 is most frequently isolated and
most strongly associated with HUS. Risk
factors for STEC O157 infections in the
United States and internationally have
been intensely studied. Non-O157 STEC
is a diverse group that includes all Shiga
toxin-producing E. coli of serogroups
other than O157. Over 50 STEC
serogroups are known to have caused
human illness. Numerous non-O157
outbreaks have been reported from
throughout the world and clinical
outcomes in some patients can be as
severe as those seen with STEC O157
infections, however, little is known
about the specific risk factors for
infections due to non-O157 STEC
serogroups. More comprehensive
understanding of risk factors for
sporadic non-O157 STEC infections is
needed to inform prevention and
control efforts.
The FoodNet case-control study is the
first multistate investigation of nonoutbreak-associated non-O157 STEC
infections in the United States. It
investigates risk factors for non-O157
STEC infections, both as a group and
individually for the most common nonO157 STEC serogroups. In addition, the
study characterizes the major known
virulence factors of non-O157 STEC to
assess how risk factors and clinical
features vary by virulence factor
profiles. As the largest, most
comprehensive, and most powerful
study of its kind, it is making an
important contribution towards better
understanding of non-O157 STEC
infections and will provide sciencebased recommendations for
interventions to prevent these
infections.
Study enrollment began between July
and September 2012 (sites had staggered
start dates) and is scheduled to run for
36 months. Since we have not yet
enrolled enough cases to meet the study
objectives, we are requesting an
extension.
Persons with non-O157 STEC
infections who are identified as part of
routine public health surveillance and
randomly selected healthy persons in
the patients’ communities (to serve as
controls) are contacted and offered
enrollment into this study. Participation
is completely voluntary and there is no
cost for enrollment. The estimated
annual burden is 268 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Patients ...........................................................
Controls ...........................................................
Case questionnaire ........................................
Control questionnaire .....................................
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–14331 Filed 6–18–14; 8:45 am]
[60Day–14–0666]
BILLING CODE 4163–18–P
emcdonald on DSK67QTVN1PROD with NOTICES
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
Proposed Data Collections Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention
The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden, invites the general public and
other Federal agencies to take this
opportunity to comment on proposed
VerDate Mar<15>2010
17:25 Jun 18, 2014
Jkt 232001
PO 00000
Frm 00019
Fmt 4703
Sfmt 4703
161
483
Number of
responses per
respondent
1
1
Average
burden per
response
(in hrs.)
25/60
25/60
and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995. To
request more information on the below
proposed project or to obtain a copy of
the information collection plan and
instruments, call 404–639–7570 or send
comments to Leroy Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
Whether the proposed collection of
information is necessary for the proper
E:\FR\FM\19JNN1.SGM
19JNN1
35167
Federal Register / Vol. 79, No. 118 / Thursday, June 19, 2014 / Notices
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Healthcare Safety Network
(NHSN) (OMB No. 0920–0666, expires
analyze antimicrobial use and/or
resistance as part of local or regional
efforts to reduce antimicrobial resistant
infections through antimicrobial
stewardship efforts or interruption of
transmission of resistant pathogens at
their facility. This revision submission
includes one new form specific to the
NHSN AUR Component.
Significant additions were made to
three NHSN facility surveys. Questions
about infection control practices were
added to gain a better understanding of
current practices and identify areas to
target prevention efforts among facilities
that have reported a multidrug-resistant
organism. Questions about antibiotic
stewardship were added to gain a better
understanding of current efforts to
improve antibiotic use in hospitals and
to assess the quality of hospital
antibiotic stewardship programs.
Additionally, minor revisions have
been made to 31 other forms within the
package to clarify and/or update
surveillance definitions. Three forms are
being removed as patient vaccination
monitoring will be removed from
NHSN.
The previously approved NSHN
package included 56 individual
collection forms; the current revision
request adds one new form and removes
three forms for a total of 54 forms. The
reporting burden will increase by
172,943 hours, for a total of 4,277,716
hours.
10/31/2016)—Revision—National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The National Healthcare Safety
Network (NHSN) is a system designed to
accumulate, exchange, and integrate
relevant information and resources
among private and public stakeholders
to support local and national efforts to
protect patients and promote healthcare
safety. Specifically, the data is used to
determine the magnitude of various
healthcare-associated adverse events
and trends in the rates of these events
among patients and healthcare workers
with similar risks. The data will be used
to detect changes in the epidemiology of
adverse events resulting from new and
current medical therapies and changing
risks. The NHSN currently consists of
five components: Patient Safety,
Healthcare Personnel Safety,
Biovigilance, Long-Term Care Facility
(LTCF), and Dialysis. Two new
components will be added within the
next one to two years: Outpatient
Procedure and Antimicrobial Use &
Resistance.
The Antimicrobial Use and Resistance
(AUR) Component will be launched
within NHSN that will specifically
examine antimicrobial use (AU) and
antimicrobial resistance (AR) within
healthcare facilities. The goal of the
AUR Component is to provide a
mechanism for facilities to report and
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
burden
hours
emcdonald on DSK67QTVN1PROD with NOTICES
Type of respondent
Form name
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Staff RN ............................................
NHSN Registration Form .................
2,000
1
5/60
167
Facility Contact Information .............
2,000
1
10/60
333
Patient Safety Component—Annual
Hospital Survey.
Group Contact Information ...............
6,000
1
50/60
5,000
1,000
1
5/60
83
Staff RN ............................................
VerDate Mar<15>2010
17:25 Jun 18, 2014
Patient Safety Monthly Reporting
Plan.
Primary Bloodstream Infection (BSI)
6,000
12
15/60
18,000
6,000
44
30/60
132,000
Pneumonia (PNEU) ..........................
6,000
72
30/60
216,000
Ventilator-Associated Event .............
6,000
144
25/60
360,000
Urinary Tract Infection (UTI) ............
6,000
40
30/60
120,000
Denominators for Neonatal Intensive
Care Unit (NICU).
Denominators for Specialty Care
Area (SCA)/Oncology (ONC).
6,000
9
3
162,000
6,000
9
5
270,000
Jkt 232001
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
E:\FR\FM\19JNN1.SGM
19JNN1
35168
Federal Register / Vol. 79, No. 118 / Thursday, June 19, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Type of respondent
Form name
Staff RN ............................................
Denominators for Intensive Care
Unit (ICU)/Other locations (not
NICU or SCA).
Surgical Site Infection (SSI) .............
Total
burden
hours
54
5
1,620,000
6,000
36
35/60
126,000
Denominator for Procedure ..............
Antimicrobial Use and Resistance
(AUR)—Microbiology Data Electronic Upload Specification Tables.
Antimicrobial Use and Resistance
(AUR)—Pharmacy Data Electronic Upload Specification Tables.
Central Line Insertion Practices Adherence Monitoring.
MDRO or CDI Infection Form ..........
6,000
6,000
540
12
5/60
5/60
270,000
6,000
6,000
12
5/60
6,000
1,000
100
5/60
8,333
6,000
72
30/60
216,000
6,000
24
15/60
36,000
6,000
240
15/60
360,000
250
1
1
250
250
8
15/60
500
250
12
5/60
250
250
9
30/60
1,125
(Infection
MDRO and CDI Prevention Process
and Outcome Measures Monthly
Monitoring.
Laboratory-identified MDRO or CDI
Event.
Long-Term Care Facility Component—Annual Facility Survey.
Laboratory-identified MDRO or CDI
Event for LTCF.
MDRO and CDI Prevention Process
Measures Monthly Monitoring for
LTCF.
Urinary Tract Infection (UTI) for
LTCF.
Monthly Reporting Plan for LTCF ....
250
12
5/60
250
(Infection
Denominators for LTCF Locations ...
250
12
3.25
9,750
(Infection
250
12
5/60
250
(Infection
Prevention
Process
Measures
Monthly Monitoring for LTCF.
LTAC Annual Survey .......................
400
1
50/60
333
(Infection
Rehab Annual Survey ......................
1,000
1
50/60
833
(Infection
Antimicrobial Use & Resistance
Component—Monthly Reporting
Plan.
Healthcare Personnel Safety Component Annual Facility Survey.
Healthcare Personnel Safety Monthly Reporting Plan.
Healthcare Worker Demographic
Data.
Exposure to Blood/Body Fluids ........
Healthcare Worker Prophylaxis/
Treatment.
Follow-Up Laboratory Testing ..........
Healthcare Worker Prophylaxis/
Treatment-Influenza.
Hemovigilance Module Annual Survey.
Hemovigilance Module Monthly Reporting Plan.
Hemovigilance Module Monthly Reporting Denominators.
Hemovigilance Adverse Reaction ....
100
12
5/60
100
50
1
8
400
11,000
1
5/60
917
50
200
20/60
3,333
50
50
50
30
1
15/60
2,500
375
50
50
50
50
15/60
10/60
625
417
500
1
2
1,000
500
12
1/60
100
500
12
1
6,000
500
48
15/60
6,000
Hemovigilance Incident ....................
500
10
10/60
833
Outpatient Procedure Component—
Annual Facility Survey.
Outpatient Procedure Component—
Monthly Reporting Plan.
5,000
1
5/60
417
5,000
12
15/60
15,000
Pharmacy Technician .......................
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
(Infection
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
(Infection
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
(Infection
(Infection
(Infection
(Infection
(Infection
(Infection
Occupational Health RN/Specialist ...
Occupational Health RN/Specialist ...
Occupational Health RN/Specialist ...
Occupational Health RN/Specialist ...
Occupational Health RN/Specialist ...
Laboratory Technician ......................
Occupational Health RN/Specialist ...
emcdonald on DSK67QTVN1PROD with NOTICES
Average
burden per
response
(in hours)
6,000
Registered
Nurse
(Infection
Preventionist).
Staff RN ............................................
Laboratory Technician ......................
Medical/Clinical Laboratory Technologist.
Medical/Clinical Laboratory Technologist.
Medical/Clinical Laboratory Technologist.
Medical/Clinical Laboratory Technologist.
Medical/Clinical Laboratory Technologist.
Staff RN ............................................
Staff RN ............................................
VerDate Mar<15>2010
Number of
responses per
respondent
17:25 Jun 18, 2014
Jkt 232001
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
E:\FR\FM\19JNN1.SGM
19JNN1
35169
Federal Register / Vol. 79, No. 118 / Thursday, June 19, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total
burden
hours
Type of respondent
Form name
Staff RN ............................................
Outpatient Procedure Component
Event.
Outpatient Procedure Component—
Monthly Denominators and Summary.
Outpatient Dialysis Center Practices
Survey.
Dialysis Monthly Reporting Plan ......
Dialysis Event ...................................
Denominators for Dialysis Event
Surveillance.
Prevention
Process
Measures
Monthly Monitoring for Dialysis.
Dialysis Patient Influenza Vaccination.
Dialysis Patient Influenza Vaccination Denominator.
State Health Department Validation
Record.
5,000
25
40/60
83,333
5,000
12
40/60
40,000
6,500
1
1.75
11,375
6,500
6,500
6,500
12
60
12
5/60
20/60
6/60
6,500
130,000
7,800
1,500
12
30/60
9,000
325
75
10/60
4,063
325
5
10/60
271
152
50
15/60
1,900
...........................................................
........................
........................
........................
4,277,716
Staff RN ............................................
Registered
Nurse
(Infection
Preventionist).
Staff RN ............................................
Staff RN ............................................
Staff RN ............................................
Staff RN ............................................
Staff RN ............................................
Staff RN ............................................
Epidemiologist ...................................
Total ...........................................
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–14339 Filed 6–18–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request; OAA Title
III–E Evaluation
Administration for Community
Living, HHS.
ACTION: Notice.
AGENCY:
The Administration for
Community Living (formerly the
Administration on Aging (AoA)) is
announcing that the proposed collection
of information listed below has been
submitted to the Office of Management
and Budget (OMB) for review and
clearance under the Paperwork
Reduction Act of 1995.
DATES: Submit written comments on the
collection of information by July 21,
2014.
emcdonald on DSK67QTVN1PROD with NOTICES
SUMMARY:
Submit written comments
on the collection of information by fax
202.395.6974 to the OMB Desk Officer
for ACL, Office of Information and
Regulatory Affairs, OMB.
ADDRESSES:
VerDate Mar<15>2010
17:25 Jun 18, 2014
Jkt 232001
FOR FURTHER INFORMATION CONTACT:
Alice-Lynn Ryssman, 202.357.3491.
SUPPLEMENTARY INFORMATION: In
compliance with PRA (44 U.S.C. 3501–
3520), the Administration for
Community Living (ACL, formerly the
Administration for Aging) has submitted
the following proposed collection of
information to the Office of
Management and Budget (OMB) for
review and clearance. The process
evaluation data collection associated
with the Title III–E National Family
Caregiver Support Program (NFCSP) is
necessary to meet three broad objectives
of ACL: (1) To provide information to
support program planning, including an
analysis of program processes, (2) to
develop information about program
efficiency and costs, and (3) gauge
program effectiveness in assessing
community and client needs, targeting
and prioritizing, and providing services
to family caregivers. The process
evaluation will examine the strategies,
activities, and resources of the program
at each level of the Aging Network—
State Unit on Aging (SUA), Area Agency
on Aging (AAA), and Local Service
Provider (LSP)—to meet the needs of
NFCSP clients/caregivers.
In response to the 60-day Federal
Register Notice related to this proposed
data collection and published on
November 20, 2013, comments from six
individuals and/or organizations were
received. Many of the suggestions, such
as to add ‘‘Dementia training’’ to the list
of options under the types of training
provided to state and local workers/
volunteers, were implemented into the
PO 00000
Frm 00022
Fmt 4703
Sfmt 9990
appropriate surveys. Suggested changes
at odds with the program definitions or
operations, such as the suggestion to
replace the term ‘‘Dementia’’ with
‘‘Neurocognitive Disorder’’ were not
adopted. In response to comments about
the length of the surveys, a few
additional questions were removed from
the State Unit on Aging (SUA) and Area
Unit on Aging (AAA) surveys.
Comments concerning the caregiver
surveys in the original 60-day notice
will be covered in a later NFCSP
outcome evaluation notice.
The process study will administer
online surveys to all 56 SUAs, all of the
618 AAAs and a sample of 1,000 LSPs.
ACL estimates the burden of this
collection of information as follows
1,566 hours for local agencies (AAAs
and LSPs) and 84 hours for the State
Units on Aging (SUAs) for a Total
Burden for Study of 1,650 hours.
The proposed data collection tools
may be found on the ACL Web site at
https://www.aoa.gov/AoARoot/Program_
Results/Program_survey.aspx.
Dated: June 16, 2014.
Kathy Greenlee,
Administrator and Assistant Secretary for
Aging.
[FR Doc. 2014–14353 Filed 6–18–14; 8:45 am]
BILLING CODE 4154–01–P
E:\FR\FM\19JNN1.SGM
19JNN1
]]>Agencies
[Federal Register Volume 79, Number 118 (Thursday, June 19, 2014)]
[Notices]
[Pages 35166-35169]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-14339]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-14-0666]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC), as part of
its continuing effort to reduce public burden, invites the general
public and other Federal agencies to take this opportunity to comment
on proposed and/or continuing information collections, as required by
the Paperwork Reduction Act of 1995. To request more information on the
below proposed project or to obtain a copy of the information
collection plan and instruments, call 404-639-7570 or send comments to
Leroy Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send
an email to omb@cdc.gov.
Comments submitted in response to this notice will be summarized
and/or included in the request for Office of Management and Budget
(OMB) approval. Comments are invited on: (a) Whether the proposed
collection of information is necessary for the proper
[[Page 35167]]
performance of the functions of the agency, including whether the
information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) ways to enhance the quality, utility, and clarity of
the information to be collected; (d) ways to minimize the burden of the
collection of information on respondents, including through the use of
automated collection techniques or other forms of information
technology; and (e) estimates of capital or start-up costs and costs of
operation, maintenance, and purchase of services to provide
information. Burden means the total time, effort, or financial
resources expended by persons to generate, maintain, retain, disclose
or provide information to or for a Federal agency. This includes the
time needed to review instructions; to develop, acquire, install and
utilize technology and systems for the purpose of collecting,
validating and verifying information, processing and maintaining
information, and disclosing and providing information; to train
personnel and to be able to respond to a collection of information, to
search data sources, to complete and review the collection of
information; and to transmit or otherwise disclose the information.
Written comments should be received within 60 days of this notice.
Proposed Project
National Healthcare Safety Network (NHSN) (OMB No. 0920-0666,
expires 10/31/2016)--Revision--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The National Healthcare Safety Network (NHSN) is a system designed
to accumulate, exchange, and integrate relevant information and
resources among private and public stakeholders to support local and
national efforts to protect patients and promote healthcare safety.
Specifically, the data is used to determine the magnitude of various
healthcare-associated adverse events and trends in the rates of these
events among patients and healthcare workers with similar risks. The
data will be used to detect changes in the epidemiology of adverse
events resulting from new and current medical therapies and changing
risks. The NHSN currently consists of five components: Patient Safety,
Healthcare Personnel Safety, Biovigilance, Long-Term Care Facility
(LTCF), and Dialysis. Two new components will be added within the next
one to two years: Outpatient Procedure and Antimicrobial Use &
Resistance.
The Antimicrobial Use and Resistance (AUR) Component will be
launched within NHSN that will specifically examine antimicrobial use
(AU) and antimicrobial resistance (AR) within healthcare facilities.
The goal of the AUR Component is to provide a mechanism for facilities
to report and analyze antimicrobial use and/or resistance as part of
local or regional efforts to reduce antimicrobial resistant infections
through antimicrobial stewardship efforts or interruption of
transmission of resistant pathogens at their facility. This revision
submission includes one new form specific to the NHSN AUR Component.
Significant additions were made to three NHSN facility surveys.
Questions about infection control practices were added to gain a better
understanding of current practices and identify areas to target
prevention efforts among facilities that have reported a multidrug-
resistant organism. Questions about antibiotic stewardship were added
to gain a better understanding of current efforts to improve antibiotic
use in hospitals and to assess the quality of hospital antibiotic
stewardship programs.
Additionally, minor revisions have been made to 31 other forms
within the package to clarify and/or update surveillance definitions.
Three forms are being removed as patient vaccination monitoring will be
removed from NHSN.
The previously approved NSHN package included 56 individual
collection forms; the current revision request adds one new form and
removes three forms for a total of 54 forms. The reporting burden will
increase by 172,943 hours, for a total of 4,277,716 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
Registered Nurse (Infection NHSN 2,000 1 5/60 167
Preventionist). Registration
Form.
Registered Nurse (Infection Facility Contact 2,000 1 10/60 333
Preventionist). Information.
Registered Nurse (Infection Patient Safety 6,000 1 50/60 5,000
Preventionist). Component--Annu
al Hospital
Survey.
Registered Nurse (Infection Group Contact 1,000 1 5/60 83
Preventionist). Information.
Registered Nurse (Infection Patient Safety 6,000 12 15/60 18,000
Preventionist). Monthly
Reporting Plan.
Registered Nurse (Infection Primary 6,000 44 30/60 132,000
Preventionist). Bloodstream
Infection (BSI).
Registered Nurse (Infection Pneumonia (PNEU) 6,000 72 30/60 216,000
Preventionist).
Registered Nurse (Infection Ventilator- 6,000 144 25/60 360,000
Preventionist). Associated
Event.
Registered Nurse (Infection Urinary Tract 6,000 40 30/60 120,000
Preventionist). Infection (UTI).
Staff RN...................... Denominators for 6,000 9 3 162,000
Neonatal
Intensive Care
Unit (NICU).
Staff RN...................... Denominators for 6,000 9 5 270,000
Specialty Care
Area (SCA)/
Oncology (ONC).
[[Page 35168]]
Staff RN...................... Denominators for 6,000 54 5 1,620,000
Intensive Care
Unit (ICU)/
Other locations
(not NICU or
SCA).
Registered Nurse (Infection Surgical Site 6,000 36 35/60 126,000
Preventionist). Infection (SSI).
Staff RN...................... Denominator for 6,000 540 5/60 270,000
Procedure.
Laboratory Technician......... Antimicrobial 6,000 12 5/60 6,000
Use and
Resistance
(AUR)--Microbio
logy Data
Electronic
Upload
Specification
Tables.
Pharmacy Technician........... Antimicrobial 6,000 12 5/60 6,000
Use and
Resistance
(AUR)--Pharmacy
Data Electronic
Upload
Specification
Tables.
Registered Nurse (Infection Central Line 1,000 100 5/60 8,333
Preventionist). Insertion
Practices
Adherence
Monitoring.
Registered Nurse (Infection MDRO or CDI 6,000 72 30/60 216,000
Preventionist). Infection Form.
Registered Nurse (Infection MDRO and CDI 6,000 24 15/60 36,000
Preventionist). Prevention
Process and
Outcome
Measures
Monthly
Monitoring.
Registered Nurse (Infection Laboratory- 6,000 240 15/60 360,000
Preventionist). identified MDRO
or CDI Event.
Registered Nurse (Infection Long-Term Care 250 1 1 250
Preventionist). Facility
Component--Annu
al Facility
Survey.
Registered Nurse (Infection Laboratory- 250 8 15/60 500
Preventionist). identified MDRO
or CDI Event
for LTCF.
Registered Nurse (Infection MDRO and CDI 250 12 5/60 250
Preventionist). Prevention
Process
Measures
Monthly
Monitoring for
LTCF.
Registered Nurse (Infection Urinary Tract 250 9 30/60 1,125
Preventionist). Infection (UTI)
for LTCF.
Registered Nurse (Infection Monthly 250 12 5/60 250
Preventionist). Reporting Plan
for LTCF.
Registered Nurse (Infection Denominators for 250 12 3.25 9,750
Preventionist). LTCF Locations.
Registered Nurse (Infection Prevention 250 12 5/60 250
Preventionist). Process
Measures
Monthly
Monitoring for
LTCF.
Registered Nurse (Infection LTAC Annual 400 1 50/60 333
Preventionist). Survey.
Registered Nurse (Infection Rehab Annual 1,000 1 50/60 833
Preventionist). Survey.
Registered Nurse (Infection Antimicrobial 100 12 5/60 100
Preventionist). Use &
Resistance
Component--Mont
hly Reporting
Plan.
Occupational Health RN/ Healthcare 50 1 8 400
Specialist. Personnel
Safety
Component
Annual Facility
Survey.
Occupational Health RN/ Healthcare 11,000 1 5/60 917
Specialist. Personnel
Safety Monthly
Reporting Plan.
Occupational Health RN/ Healthcare 50 200 20/60 3,333
Specialist. Worker
Demographic
Data.
Occupational Health RN/ Exposure to 50 50 1 2,500
Specialist. Blood/Body
Fluids.
Occupational Health RN/ Healthcare 50 30 15/60 375
Specialist. Worker
Prophylaxis/
Treatment.
Laboratory Technician......... Follow-Up 50 50 15/60 625
Laboratory
Testing.
Occupational Health RN/ Healthcare 50 50 10/60 417
Specialist. Worker
Prophylaxis/
Treatment-
Influenza.
Medical/Clinical Laboratory Hemovigilance 500 1 2 1,000
Technologist. Module Annual
Survey.
Medical/Clinical Laboratory Hemovigilance 500 12 1/60 100
Technologist. Module Monthly
Reporting Plan.
Medical/Clinical Laboratory Hemovigilance 500 12 1 6,000
Technologist. Module Monthly
Reporting
Denominators.
Medical/Clinical Laboratory Hemovigilance 500 48 15/60 6,000
Technologist. Adverse
Reaction.
Medical/Clinical Laboratory Hemovigilance 500 10 10/60 833
Technologist. Incident.
Staff RN...................... Outpatient 5,000 1 5/60 417
Procedure
Component--Annu
al Facility
Survey.
Staff RN...................... Outpatient 5,000 12 15/60 15,000
Procedure
Component--Mont
hly Reporting
Plan.
[[Page 35169]]
Staff RN...................... Outpatient 5,000 25 40/60 83,333
Procedure
Component Event.
Staff RN...................... Outpatient 5,000 12 40/60 40,000
Procedure
Component--Mont
hly
Denominators
and Summary.
Registered Nurse (Infection Outpatient 6,500 1 1.75 11,375
Preventionist). Dialysis Center
Practices
Survey.
Staff RN...................... Dialysis Monthly 6,500 12 5/60 6,500
Reporting Plan.
Staff RN...................... Dialysis Event.. 6,500 60 20/60 130,000
Staff RN...................... Denominators for 6,500 12 6/60 7,800
Dialysis Event
Surveillance.
Staff RN...................... Prevention 1,500 12 30/60 9,000
Process
Measures
Monthly
Monitoring for
Dialysis.
Staff RN...................... Dialysis Patient 325 75 10/60 4,063
Influenza
Vaccination.
Staff RN...................... Dialysis Patient 325 5 10/60 271
Influenza
Vaccination
Denominator.
Epidemiologist................ State Health 152 50 15/60 1,900
Department
Validation
Record.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 4,277,716
----------------------------------------------------------------------------------------------------------------
Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-14339 Filed 6-18-14; 8:45 am]
BILLING CODE 4163-18-P
